NovoPath: Lighting the Way in Digital Pathology and AI

We are in an era in which medical diagnosis is being transformed by fast data and intelligent algorithms, and pathology is experiencing a paradigm shift not seen since the invention of the microscope. At the forefront of such a paradigm shift is NovoPath, a firm that has taken more than 30 years to transform from a conventional Laboratory Information System (LIS) vendor to a world leader in digital pathology and integration with artificial intelligence.

As a driver of the workflow first revolution, NovoPath ensures the diagnostic laboratory of the future is faster, more accurate, and fully connected. By 2026, the company is the infrastructure of choice for labs on a switch to a data driven world.

From Glass to Digital

Historically, pathology has been reliant upon the physical transport of glass slides for well over a hundred years. This has meant that the process has been very slow and inefficient from a geographical perspective, with the slides being transported and stored in archives. NovoPath has assisted in the break through of these barriers through the use of Whole Slide Imaging (WSI) technology.

Through collaboration with some of the largest FDA-approved scanner manufacturers, NovoPath enables labs to convert actual tissue specimens into valuable digital content. These digital slides are more than a substitute for the microscope; they enhance it. Pathologists can zoom in and out in seconds, mark regions of interest, and consult experts instantly around the globe.

The Workflow First Mindset

One of the biggest challenges for digital pathology has been viewer fatigue, which is being frustratingly shuttled between viewing software and reporting software. This is addressed by NovoPath’s workflow-oriented approach.

Instead of viewing the image as a standalone file, NovoPath integrates the digital slide directly into the diagnostic process.

• Integrated Environment: Pathologists can review specimen information, clinical history, and image data all on one screen. Say goodbye to jumping between various pieces of software.
• Efficiency Gains: The system reduces clicks to a minimum. Some of the labs utilizing NovoPath have seen reductions of up to 85 percent in task completion times, where report results take seconds compared to minutes.
• Automatic Case Distribution: The system employs intelligent rules to distribute cases to the most qualified and available pathologist, thereby eliminating manual distribution and cherry picking.

AI: From Sci-Fi to Real Life Clinical Utility

Artificial intelligence is not just a buzzword at NovoPath but an actual layer of their LIS solution. They are aware that it is not possible for an AI system to replace a pathologist, but it can serve as an excellent co-pilot to handle volumes and repetitive tasks, reducing pathologist fatigue.

1. Intelligent Triage

It immediately reviews the digital slides once they are uploaded, identifies cases that are either high priority or STAT cases such as suspected malignancies, and brings them to the top of the worklist.

2. Automated Quantification

Manual counting or measurement of cells or biomarkers is a time-consuming and error-prone process. The use of AI integration by NovoPath automates the scoring of biomarkers such as HER2 or Ki 67 in breast cancer, providing standardized and reproducible results that enhance diagnostic confidence.

3. Quality Control

The safety net of AI will pick up any slide mismatches, missed tissue blocks, or note and visual inconsistencies before finalizing the report. Such levels of automated QC are critical to ensuring that CAP and CLIA requirements are met.

A Full Ecosystem for Multi-Specialty Labs

Modern pathology labs are no longer about anatomy alone. They also involve molecular, genetic, or veterinary pathology. NovoPath is developed as a multi-specialty hub.

• Molecular Integration: This provides Next Gen Sequencing (NGS) and FISH capabilities so that the lab results regarding anatomy, as well as genetic information, can be integrated in a single report for a patient.
• Agnostic Interfacing: With more than 150 EMR interfaces and support for a wide range of laboratory instruments, NovoPath ensures a seamless stream of information from grossing to billing.
• Cloud Native Security: Based on Microsoft Azure and having SOC 2 Type II and HIPAA compliance, this ensures robust security for patients’ genomic and diagnostic information.

The Economic Impact: Scale Without More Staff

The shortage of pathologists is an increasing concern in the healthcare industry. This is where NovoPath helps scale the lab horizontally by automating manual data entry, specimen management, and reporting, enabling the lab to process many more cases without the need to hire additional pathologists.

Leading Through Innovation

The thought of going digital in pathology can be intimidating, but NovoPath makes it much easier. It is also vendor-agnostic, allowing labs to choose the hardware that best suits them while maintaining a consistent software experience. This is important in a constantly shifting technology environment where the best scanner available today could be obsolete tomorrow.

In addition, NovoPath offers real-time business intelligence. Lab directors receive turnaround time and pathologist productivity reports, as well as reports on stain usage. Such data management allows labs to function like well-organized businesses and identify bottlenecks in time to avoid impacting patient care.

Looking Ahead: The Future of NovoPath

As 2026 unfolds, NovoPath continues to advance predictive analytics. The future of NovoPath not only lies in predicting what is on the slide but in using deep learning algorithms to predict what might happen to the patient in response to treatment based on patterns not visible to the naked eye.

With CEO Promise Okeke at the helm, NovoPath remains committed to its customers. They are not only a software company but a partner for the lab to transform its operations end to end. With 30 years of experience combined with the latest advancements in AI, NovoPath is not only a part of the digital pathology movement but is actually leading the charge for the industry as a whole. As the complexity of diagnostic medicine escalates, a comprehensive, intelligent, secure platform is a necessity. NovoPath remains steadfast in their commitment to providing pathologists the tools they need to do what they do best: provide irrefutable answers that can save lives.